U.S. Food Stock News

Weave Communications (WEAV) just posted its Q1 2026 numbers, with revenue of US$65.5 million, a basic EPS loss of US$0.07, and net income loss of US$5.77 million setting the tone for the quarter. Over the past year, the company has seen quarterly revenue move from US$55.8 million in Q1 2025 to US$65.5 million in Q1 2026, while basic EPS losses have ranged between roughly US$0.02 and US$0.12 per quarter. For you as an investor, the story this quarter is about a business adding revenue while...

F5 (FFIV) has put fresh numbers on the board for Q2 2026, reporting revenue of US$811.7 million and basic EPS of US$2.61, with trailing 12 month EPS at US$12.33 on revenue of US$3.2 billion. Over recent quarters the company has seen revenue move from US$731.1 million and EPS of US$2.51 in Q2 2025 to US$810.1 million and EPS of US$3.30 in Q4 2025, before landing at the latest Q2 2026 levels. This sets up the latest release as a check in on how earnings growth and margins are holding up. See...

Hut 8 (HUT) opened 2026 with Q1 revenue of US$71.0 million, a basic EPS loss of US$1.98, and a net loss excluding extra items of US$219.8 million. On a trailing 12‑month basis, revenue stood at US$284.3 million and basic EPS was a loss of US$2.90 on a US$311.4 million net loss. Over recent quarters the company has seen revenue move from US$21.8 million in Q1 2025 to US$88.5 million in Q4 2025 before landing at US$71.0 million in Q1 2026. This came alongside basic EPS that has swung between a...

How Hercules Capital's Latest Numbers Set the Stage for the Current Debate Hercules Capital (HTGC) has opened 2026 with Q1 revenue of US$141.5 million and basic EPS of US$0.23, alongside trailing twelve month revenue of US$554.5 million and EPS of US$1.83 that reflect the strong 49.4% earnings growth recorded over the past year. Over recent quarters the company has seen revenue move from US$119.5 million in Q1 2025 to US$141.5 million in Q1 2026, with quarterly EPS ranging from US$0.29 to...

American Well Q1 2026 earnings snapshot American Well (AMWL) opened 2026 with Q1 revenue of US$54.9 million and a basic EPS loss of US$0.66, alongside a trailing twelve month EPS loss of US$5.40 on revenue of US$237.4 million. The company reported a change in quarterly revenue from US$66.8 million in Q1 2025 to US$54.9 million in Q1 2026, while quarterly EPS losses across that period have ranged between about US$0.66 and US$2.77. These figures provide the context for assessing current...

IQVIA Holdings (IQV) Q1 2026 earnings snapshot IQVIA Holdings (IQV) opened 2026 with Q1 revenue of about US$4.2b and basic EPS of US$1.63, setting the tone for how its earnings profile is evolving after a year in which trailing 12 month EPS came in at US$8.14 on revenue of about US$16.6b. Over the last five reported quarters, the company has seen quarterly revenue move from US$3.8b in Q1 2025 to US$4.2b in Q1 2026, while basic EPS across those prints has ranged between US$1.42 and US$3.02,...

Silicon Laboratories (SLAB) opened Q1 2026 with revenue of US$213.5 million and a basic EPS loss of US$0.48, as net income excluding extra items came in at a loss of US$15.9 million. The company has seen quarterly revenue move from US$166.2 million in Q4 2024 to US$177.7 million in Q1 2025, then to US$213.5 million in Q1 2026. Over the same quarters, EPS shifted from a loss of US$0.73 to a loss of US$0.94 and then to a loss of US$0.48. For investors, the key question is whether this top line...

Ultragenyx Pharmaceutical (RARE) opened Q1 2026 with revenue of US$136 million and basic EPS of US$1.84 loss, while trailing twelve month figures show revenue of US$670 million and basic EPS of US$6.11 loss. Over recent quarters, revenue has moved between US$139.3 million in Q1 2025 and US$207.3 million in Q4 2025, as basic EPS losses ranged from US$1.17 to US$1.81 per quarter. This gives investors a clear view of how top line growth is running ahead of earnings. For anyone watching margins...

Cencora (COR) just released its second quarter results, with sales of US$78.4b and net income of US$1.6b, drawing fresh attention to how the stock reflects its healthcare distribution and specialty pharma exposure. See our latest analysis for Cencora. The earnings release has arrived alongside a sharp reset in sentiment, with the share price at US$252.74 after a 1-day share price return decline of 17.38% and a 90-day share price return decline of 28.23%. However, the 5-year total shareholder...

Southwest Gas Holdings (SWX) opened 2026 with Q1 revenue of US$585.1 million and basic EPS of US$1.91, setting the tone for how investors may read the rest of the year. The company has seen quarterly revenue move from US$553.1 million in Q4 2024 to US$585.1 million in Q1 2026, while basic EPS has ranged from US$1.18 in Q4 2024 to US$1.91 in the latest quarter. This gives investors a clear view of how the top and bottom line are tracking as margins and profitability stay in focus. See our full...

Investors may be wondering whether Autoliv stock now reflects its underlying value, or if the recent attention has left some mispricing on the table. The share price recently closed at US$121.25, with returns of 7.0% over 7 days, 15.2% over 30 days, 33.2% over 1 year, 49.8% over 3 years, 44.3% over 5 years and a small year to date loss of 0.7%. Recent coverage has focused on Autoliv as a key player in vehicle safety systems. This helps frame how investors are thinking about its earnings...

Match Group (MTCH) opened 2026 with Q1 revenue of US$863.9 million and basic EPS of US$0.71, setting the tone for how the business is entering the new year. The company has seen quarterly revenue move from US$831.2 million and EPS of US$0.47 in Q1 2025 through a series of higher and lower prints over 2025 to the latest Q1 2026 figures, giving investors a fuller view of how the top and bottom lines have tracked over the last five reported quarters. With trailing 12 month EPS at US$2.78 and net...

Wondering whether StoneX Group stock still offers value after its strong run, or if you might be late to the party? This article breaks down what the current price could mean for you. At a recent close of US$106.39, the stock shows returns of 2.6% over 7 days, 24.3% over 30 days, 63.9% year to date and 69.5% over 1 year, with a very large 5 year return of 436.3%. Recent news coverage has focused on StoneX Group's role as a global financial services company and its position in capital...

Why BXP Stock Is on Investors’ Radar Today BXP (BXP) shares have recently shown mixed short term performance, with a gain of about 4% over the past week and roughly 15% over the past month, while the past 3 months remain weaker. See our latest analysis for BXP. At a share price of $59.84, BXP’s recent 15.3% 1 month share price return contrasts with its weaker year to date performance and slightly negative 1 year total shareholder return of 2.0%. This suggests momentum has picked up after a...

Seaboard's Q1 2026 Earnings Snapshot Seaboard (SEB) opened 2026 with Q1 total revenue of US$2.4b, basic EPS of US$124.24 and net income of US$119m, setting a fresh reference point against last year’s sharp earnings rebound. Over recent quarters the company has seen quarterly revenue move from US$2.316b in Q1 2025 to around the US$2.4b range in Q1 2026. Basic EPS shifted from US$32.95 to US$124.24. Trailing twelve month EPS reached US$606.79 alongside net income of US$583m on US$9.83b of...

Rayonier Advanced Materials (RYAM) opened 2026 with Q1 revenue of US$319 million and a basic EPS loss of US$1.21, alongside trailing 12 month revenue of about US$1.4 billion and a basic EPS loss of US$7.08. Over recent quarters the company has seen revenue move from US$422.5 million in Q4 2024 to US$355.9 million in Q1 2025, US$340.0 million in Q2 2025, US$352.8 million in Q3 2025, US$417.5 million in Q4 2025 and now US$319 million in Q1 2026, while quarterly basic EPS losses have ranged...

Devon Energy (DVN) opened 2026 with Q1 revenue of US$4.3b and basic EPS of US$0.19 on net income of US$120m, setting a cautious tone for the new year. Over the past few quarters, the company has seen revenue move between US$3.8b and US$4.3b, while quarterly EPS has ranged from about US$0.77 to US$1.42. This has contributed to trailing twelve month EPS of US$3.63 on revenue of US$16.0b. Investors are therefore likely to focus on how much of that top line converts into profit as margins adjust...

Grab Holdings (NasdaqGS:GRAB) opened 2026 with Q1 revenue of US$955 million and basic EPS of US$0.03, setting a clear marker for how its ride hailing and delivery platform is currently translating scale into per share earnings. The company has seen quarterly revenue move from US$773 million in Q1 2025 to US$955 million in Q1 2026, while basic EPS has shifted from US$0.01 to US$0.03 over the same period. Trailing twelve month EPS now sits at US$0.09 on revenue of US$3.6 billion, giving...

Bioventus (BVS) opened 2026 with Q1 revenue of US$132.1 million and basic EPS of US$0.05, alongside trailing twelve month revenue of US$576.3 million and basic EPS of US$0.43 that reflect a period of positive net income. Over recent quarters the company has seen revenue range from US$123.9 million to US$157.9 million, while basic EPS moved from a loss of US$0.04 in early 2025 to US$0.22 in Q4 2025 and US$0.05 in the latest quarter, setting up a narrative that now hinges on how durable these...

Q1 2026 headline results and setup Corteva (CTVA) opened 2026 with Q1 revenue of US$4.9 billion and basic EPS of US$1.07, with trailing twelve month net income of US$1.25 billion giving investors a fuller view of the current earnings run rate. The company reported quarterly revenue of US$4.42 billion in Q1 2025 and US$4.91 billion in Q1 2026, while basic EPS moved from US$0.97 to US$1.07 over the same period as trailing net profit margins held close to 7%. With earnings growth forecasts...

Solventum (SOLV) opened Q1 2026 with revenue of US$2.0 billion and basic EPS of US$0.07, putting fresh numbers on the table for investors focused on how its earnings profile is evolving. Over the past few reporting periods, revenue has moved between US$2.1 billion in Q1 2025 and US$2.0 billion in Q1 2026, while basic EPS shifted from US$0.79 in Q1 2025 to US$0.07 in the latest quarter, with the trailing twelve months showing revenue of US$8.3 billion and basic EPS of US$8.22. This mix of...

Standard BioTools (LAB) has kicked off Q1 2026 with revenue of about US$21.1 million and a basic EPS loss of roughly US$0.04. This sets a cautious tone around how much of that top line is flowing through to the bottom line. The company has seen quarterly revenue move between roughly US$19.6 million and US$24.8 million since Q4 2024, while basic EPS has ranged from a loss of about US$0.08 to a profit of roughly US$0.04 over the same period. This underscores how sensitive margins have been to...

Tempus AI (TEM) opened Q1 2026 with revenue of US$348.1 million and a basic EPS loss of US$0.70, while trailing 12 month figures show US$1.4 billion in revenue and a basic EPS loss of US$1.72. This keeps the focus firmly on scaling rather than profitability. Over recent quarters the company has seen revenue move from US$255.7 million in Q1 2025 to US$348.1 million in Q1 2026, with basic EPS losses ranging between US$0.25 and US$0.70 per quarter across that period. For you as an investor, this...

CRISPR Therapeutics (NasdaqGM:CRSP) has expanded its lead CAR-T program, zugo-cel, into new autoimmune disease indications. The company advanced multiple in vivo liver-directed gene editing and siRNA programs into clinical development. CASGEVY, its gene-editing therapy, continues to see commercial traction, and a recent regulatory filing aims to extend its label to younger pediatric patients. A major convertible notes offering has strengthened the balance sheet and is funding a broader...